Caracterización espectroscópica del D-003 obtenido de la cera de caña de azúcar (Saccharum officinarum L. ) / Spectroscopic characterization of D-003 obtained from the sugar cane (Saccharum officinarum L. ) wax

Introducción: el D-003 es un ingrediente farmacéutico activo purificado a partir de la cera de caña de azúcar (Saccharum officinarum L.) con efectos como reductor del colesterol y antioxidante, el cual está compuesto por una mezcla de ácidos grasos libres saturados de elevado peso molecular, cada uno dentro de un intervalo de concentración específica determinada por cromatografía de gases (CG). La caracterización espectroscópica del D-003, sin embargo, no ha sido previamente informada. Objetivo: caracterizar el ingrediente farmacéutico activo nombrado D-003 de acuerdo con sus espectros ultravioleta (UV), infrarrojo (FTIR), resonancia magnética nuclear (RMN) y de masas (EM). Métodos: se evaluaron muestras de seis lotes de D-003 (CNIC, Cuba) mediante las técnicas de UV, FTIR, RMN-¹H, RMN-13C y CG-EM. Para obtener los espectros de masas de los ácidos del D-003, estos se derivaron como ésteres metílicos y trimetilsilil. La cuantificación de los ácidos grasos libres saturados de elevado peso molecular, analizados como ésteres metílicos, se llevó a cabo por CG con detector de ionización por llama (DILL). Resultados: los espectros UV, IR, RMN-¹H y RMN-13C mostraron que el ingrediente farmacéutico activo D00-3 está constituido por una mezcla de ácidos grasos libres saturados de elevado peso molecular, mientras las técnicas de CG-EM y CG-DILL permitieron asegurar la presencia de 13 ácidos grasos libres saturados de elevado peso molecular en proporciones definidas: C24:0 (0,2-0,6 por ciento), C25:0 (0,4-0,9 por ciento), C26:0 (2,0-3,1 por ciento), C27:0 (2,1-2,7 por ciento), C28:0 (30,0-37,5 por ciento), C29:0 (1,5-1,7 por ciento), C30:0 (17,0-18,6 por ciento), C31:0 (0,9-1,2 por ciento), C32:0 (6,9-8,9 por ciento), C33:0 (0,9-1,3 por ciento), C34:0 (7,2-11,1 por ciento), C35:0 (0,3-0,6 por ciento) y C36:0 (2,2-3,8 por ciento)(AU)

Introduction: D-003, an active pharmaceutical ingredient (API) purified from sugar cane (Saccharum officinarum L.) wax with cholesterol-lowering and antioxidant effects, is composed of a mixture of free saturated very long chain fatty acids (VLCFAs), each within specific relative concentration ranges as determined by the gas chromatography (GC). However, the spectroscopic characterization of D-003 had not been previously reported. Objective: to characterize the active pharmaceutical ingredient named D003 in accordance to its ultraviolet (UV), infrared (FTIR), nuclear magnetic resonance (NMR) and mass (MS) spectra. Methods: samples of six batches of D-003 (CNIC, Cuba) were evaluated by UV, FTIR, NMR-¹H, NMR-13C, and GC-MS techniques. For obtaining the mass spectra of D-003 acids, methyl (FAME) and trimethylsilyl ester derivatives were used. Quantification of free very long chain saturated fatty acids , analyzed as methyl ester derivatives, was made by GC with flame ionisation detector (FID). Results: UV, FTIR, and ¹H-NMR, 13C-NMR spectra showed that active pharmaceutical ingredient D-003 was composed of a mixture of free very long chain fatty acids, whereas the GC-MS and GC-FID techniques allowed ensuring the occurrence of 13 VLCFAs in set proportions: C24:0 (0.2-0.6 percent), C25:0 (0.4-0.9 percent), C26:0 (2.0-3.1 percent), C27:0 (2.1-2.7 percent), C28:0 (30.0-37.5 percent), C29:0 (1.5-1.7 percent), C30:0 (17.0-18.6 percent), C31:0 (0.9-1.2 percent), C32:0 (6.9-8.9 percent), C33:0 (0.9-1.3 percent), C34:0 (7.2-11.1 percent), C35:0 (0.3-0.6 percent) and C36:0 (2.2-3.8 percent). Conclusions: evidences from the UV, FTIR, NMR and GC-MS spectroscopic techniques prove that D-003 is composed of 13 saturated very long chain fatty acids, including octacosanoic acid as the most abundant one(AU)

Caracterización espectroscópica del D-003 obtenido de la cera de caña de azúcar (Saccharum officinarum L. ) / Spectroscopic characterization of D-003 obtained from the sugar cane (Saccharum officinarum L. ) wax

Introducción: el D-003 es un ingrediente farmacéutico activo purificado a partir de la cera de caña de azúcar (Saccharum officinarum L.) con efectos como reductor del colesterol y antioxidante, el cual está compuesto por una mezcla de ácidos grasos libres saturados de elevado peso molecular, cada uno dentro de un intervalo de concentración específica determinada por cromatografía de gases (CG). La caracterización espectroscópica del D-003, sin embargo, no ha sido previamente informada. Objetivo: caracterizar el ingrediente farmacéutico activo nombrado D-003 de acuerdo con sus espectros ultravioleta (UV), infrarrojo (FTIR), resonancia magnética nuclear (RMN) y de masas (EM). Métodos: se evaluaron muestras de seis lotes de D-003 (CNIC, Cuba) mediante las técnicas de UV, FTIR, RMN-¹H, RMN-13C y CG-EM. Para obtener los espectros de masas de los ácidos del D-003, estos se derivaron como ésteres metílicos y trimetilsilil. La cuantificación de los ácidos grasos libres saturados de elevado peso molecular, analizados como ésteres metílicos, se llevó a cabo por CG con detector de ionización por llama (DILL). Resultados: los espectros UV, IR, RMN-¹H y RMN-13C mostraron que el ingrediente farmacéutico activo D00-3 está constituido por una mezcla de ácidos grasos libres saturados de elevado peso molecular, mientras las técnicas de CG-EM y CG-DILL permitieron asegurar la presencia de 13 ácidos grasos libres saturados de elevado peso molecular en proporciones definidas: C24:0 (0,2-0,6 por ciento), C25:0 (0,4-0,9 por ciento), C26:0 (2,0-3,1 por ciento), C27:0 (2,1-2,7 por ciento), C28:0 (30,0-37,5 por ciento), C29:0 (1,5-1,7 por ciento), C30:0 (17,0-18,6 por ciento), C31:0 (0,9-1,2 por ciento), C32:0 (6,9-8,9 por ciento), C33:0 (0,9-1,3 por ciento), C34:0 (7,2-11,1 por ciento), C35:0 (0,3-0,6 por ciento) y C36:0 (2,2-3,8 por ciento)(AU)

Introduction: D-003, an active pharmaceutical ingredient (API) purified from sugar cane (Saccharum officinarum L.) wax with cholesterol-lowering and antioxidant effects, is composed of a mixture of free saturated very long chain fatty acids (VLCFAs), each within specific relative concentration ranges as determined by the gas chromatography (GC). However, the spectroscopic characterization of D-003 had not been previously reported. Objective: to characterize the active pharmaceutical ingredient named D003 in accordance to its ultraviolet (UV), infrared (FTIR), nuclear magnetic resonance (NMR) and mass (MS) spectra. Methods: samples of six batches of D-003 (CNIC, Cuba) were evaluated by UV, FTIR, NMR-¹H, NMR-13C, and GC-MS techniques. For obtaining the mass spectra of D-003 acids, methyl (FAME) and trimethylsilyl ester derivatives were used. Quantification of free very long chain saturated fatty acids , analyzed as methyl ester derivatives, was made by GC with flame ionisation detector (FID). Results: UV, FTIR, and ¹H-NMR, 13C-NMR spectra showed that active pharmaceutical ingredient D-003 was composed of a mixture of free very long chain fatty acids, whereas the GC-MS and GC-FID techniques allowed ensuring the occurrence of 13 VLCFAs in set proportions: C24:0 (0.2-0.6 percent), C25:0 (0.4-0.9 percent), C26:0 (2.0-3.1 percent), C27:0 (2.1-2.7 percent), C28:0 (30.0-37.5 percent), C29:0 (1.5-1.7 percent), C30:0 (17.0-18.6 percent), C31:0 (0.9-1.2 percent), C32:0 (6.9-8.9 percent), C33:0 (0.9-1.3 percent), C34:0 (7.2-11.1 percent), C35:0 (0.3-0.6 percent) and C36:0 (2.2-3.8 percent). Conclusions: evidences from the UV, FTIR, NMR and GC-MS spectroscopic techniques prove that D-003 is composed of 13 saturated very long chain fatty acids, including octacosanoic acid as the most abundant one(AU)

Validation of a gas chromatographic method for determining fatty acids that compose D003 in 10 mg film-coated tablets.

D003 is a new product composed of a mixture of aliphatic fatty acids (C(24:0) to C(36:0)), which shows antiplatelet, antithrombotic, antioxidant, and cholesterol-lowering effects in experimental models and human beings. A gas chromatographic method using a DB-5 wide-bore column and 1-nonadecanoic acid as internal standard was developed and validated in order to determine D003 in 10 mg film-coated tablets. The acids were analysed as methyl esters derivatives, prepared using 5% aqueous HCl-methanol. Developed method was specific for the active principle, even when samples were subjected to stress conditions. Good linearity (correlation coefficient > 0.99) and accuracy (total average recovery = 100.29%) were proven over a range 50-150% of the nominal concentration. Within-day and intermediate precisions at the nominal dose (100%) were < 1.5%. Robustness was examined through an intralaboratory study, quantification and resolution were only affected by the injection volume increase and no other of the 7 operational changes evaluated affected the results. The method was suitable for quality control and stability studies of these tablets.